Gilad Oren
Aprea Therapeutics, Inc. · President/CEO
Gilad Oren is listed in filings as President/CEO at Aprea Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 16, 2026, including purchase activity. Recent filings connect the profile to Aprea Therapeutics, Inc. (APRE). The current snapshot covers public activity from Oct 15, 2024 to Mar 16, 2026. Reported amounts are shown as $61.7K to $21.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $25k28.1k shares | BuyJan 30, 2026 | $0.89 | $0.6816 | |
| $21k28.1k shares | BuyJan 30, 2026 | $0.765 | $0.6816 |